Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumour promotion and treatment

Immunology and Cell Biology

Volumn 78, Issue 4, 2000, Pages 436-441

  Roberts Thomson, S J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cell cycle; Nuclear receptor; Peroxisome proliferator activated receptor; Transcription factor; Tumorigenesis

Indexed keywords

CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN BCL 2; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR; TROGLITAZONE;

ADIPOCYTE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; COLORECTAL CANCER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; COLONIC NEOPLASMS; HUMANS; LIPID METABOLISM; LIVER NEOPLASMS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0033849091     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00921.x     Document Type: Article

References (87)

1. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
2. The organization, promoter analysis, and expression of the human PPARgamma gene
3. PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter
4. Peroxisome proliferator-activated receptors: Finding the orphan a home
5. The steroid and thyroid hormone receptor super-family
6. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
7. The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor
8. The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo
9. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene
10. Increasing the complexity of coactivation in nuclear receptor signaling
11. Regulation of peroxisome proliferator-activated receptors
12. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
13. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
14. Ligand selectivity of the peroxisome proliferator-activated receptor alpha
15. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
16. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/ 3-hydroxyacyl- CoA dehydrogenase
17. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription
18. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner
19. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR
20. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators
21. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals
22. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
23. Localization of the peroxisome proliferator-activated receptor in the brain
24. Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs
25. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators
26. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotrop c effects of peroxisome proliferators
27. Role ofP PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14, 643
28. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino) -2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liven
29. Hepatocarcinogenesis of peroxisome proliferators
30. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver
31. Expression of cyclins and cdks throughout murne carcinogenesis
32. Function of the c-Myc oncogenic transcription factor
33. Decreased hepatocyte growth factor level by Wy-14, 643, non-genotoxic hepatocarcinogen in F-344 rats
34. Growth regulation by peroxisome proliferators Opposing activities in early and late GI
35. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin
36. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens
37. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARα)
38. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of peroxisome proliferators
39. Apoptosis and proliferation in nongenotoxic carcinogenesis: Species differences and role of PPARalpha
40. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis
41. Drug treatment of lipid disorders
42. Recent update on the PPAR alpha-null mouse
43. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
44. Peroxisome proliferator activated receptor-alpha expression in human liver
45. A peroxisome proliferator-activated receptor-alpha (PPARalpha) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARalpha: Implications for species differences in responses to peroxisome proliferators
46. The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is reactive among a sample human population: Significance for species differences m response to PPs
47. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
48. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha
49. The PPARalpha-leukotriene B4 pathway to inflammation control
50. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12, 13-myristate-type tumor promoters in immortalized mouse liver cells
51. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
52. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
53. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers
54. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands
55. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
56. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
57. Differential expression of peroxisome proliferatoractivated receptor-alpha, -beta, and -gamma during rat embryonic development
58. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes
59. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system
60. Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function
61. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
62. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors
63. Expression of peroxisome proIiferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts
64. Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells
65. Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures
66. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ
67. Lessons from hereditary colorectal cancer
68. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos
69. Functional interaction of beta-catenin with the transcription factor LEF-1
70. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention
71. PPARgamma, the ultimate thrifty gene
72. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients
73. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
74. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
75. A Pro l2Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
76. PPARgamma induces ceil cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
77. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
78. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
79. Terminal differentiation of human breast cancer through PPARgamma
80. MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response
81. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
82. The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers
83. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
84. Loss-of-function mutations in PPAR gamma associated with human colon cancer
85. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
86. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumours in C57BL/6J-APCmin/+ mice
87. Receptor and nonreceptor-mediated organ-specific toxicity of di (2-ethylhexyl) phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice